Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK of Oral Testosterone Undecanoate With Curcumin in Men With Induced Hypogonadism
NCT06312761Phase 2Not yet recruiting
- Sponsor
- University of Washington
- Start
- Jun 2024
- Primary completion
- Dec 2025
- Modality
- Hormone, Biologic
01
Overview
A Phase 2 trial of testosterone undecanoate in Hypogonadism, sponsored by University of Washington. Planned start Jun 2024; status: not yet recruiting.
02
Drugs
testosterone undecanoate
03
Conditions
Hypogonadism
Beyond the preview
Go deeper on NCT06312761.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06312761.